Skip to Content
Center for International Blood and Marrow Transplant Research

AD09-01

Main Content

Long-term outcomes after autologous hematopoietic cell transplantation for severe multiple sclerosis.

Study #: AD09-01

Study Status: Published

Presentation(s)

2013, EBMT (Oral)

Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis.

Citation

Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R.

JAMA Neurology. 2017, Apr 01: 74(4): 74(4):459-469. doi: 10.1001/jamaneurol.2016.5867. Epub 2017, Feb 20. PMCID:PMC5744858.

PubMed

PMID: 28241268

Abstract